Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone.
已完结20由 羕 发布于 2025/12/19 14:49:43
DOI:10.1182/blood.2025030113
作者:Luca Bertamini,Cathelijne Fokkema,Paula Rodriguez-Otero,Mark van Duin,Evangelos Terpos,Mattia D'Agostino,Vincent H J van der Velden,Niels W C J van de Donk,Michel Delforge,Christoph Driessen,Roman Haj
文献类型:期刊论文
补充材料:只需要正文